Campbell & CO Investment Adviser LLC Has $5.54 Million Stock Position in The Clorox Company $CLX

Key Points

• Campbell & CO Investment Adviser LLC increased its holdings in The Clorox Company by 318.5%, owning 37,624 shares valued at approximately $5.54 million as of the latest quarter.
• Clorox reported earnings per share of $2.87 for the recent quarter, exceeding the consensus estimate of $2.24, and experienced a 4.5% year-over-year revenue growth.
• The company recently declared a quarterly dividend of $1.24 per share, raising its annualized dividend yield to 4.1%, compared to the previous dividend of $1.22.

Campbell & CO Investment Adviser LLC boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 318.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 37,624 shares of the company's stock after buying an additional 28,633 shares during the quarter. Clorox makes up approximately 0.4% of Campbell & CO Investment Adviser LLC's investment portfolio, making the stock its 23rd largest position. Campbell & CO Investment Adviser LLC's holdings in Clorox were worth $5,540,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Wood Tarver Financial Group LLC acquired a new position in Clorox during the fourth quarter worth approximately $31,000. GW&K Investment Management LLC increased its position in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after buying an additional 208 shares during the last quarter. Roble Belko & Company Inc boosted its holdings in shares of Clorox by 140.7% during the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock worth $53,000 after acquiring an additional 211 shares during the period. IMA Advisory Services Inc. bought a new stake in shares of Clorox during the first quarter worth approximately $58,000. Finally, Menard Financial Group LLC bought a new stake in shares of Clorox during the fourth quarter worth approximately $63,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CLX. Citigroup restated a "neutral" rating and set a $135.00 price objective (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. JPMorgan Chase & Co. reduced their price objective on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Evercore ISI set a $140.00 price objective on Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Wells Fargo & Company boosted their price objective on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday, August 1st. Finally, Barclays reduced their price objective on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Reduce" and an average price target of $143.36.

Clorox Trading Up 0.3%

Shares of CLX stock opened at $120.1760 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market cap of $14.70 billion, a P/E ratio of 18.43, a price-to-earnings-growth ratio of 0.96 and a beta of 0.49. The stock has a 50 day simple moving average of $124.25 and a 200 day simple moving average of $135.30. The Clorox Company has a 1 year low of $117.35 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same period in the prior year, the company earned $1.82 earnings per share. The company's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date is Wednesday, August 13th. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.